Cargando…
Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis
BACKGROUND AND AIMS: Polymorphisms near the membrane bound O-acyltransferase domain containing 7 (MBOAT7) genes are associated with worsened nonalcoholic fatty liver (NASH), and nonalcoholic fatty liver disease (NAFLD)/NASH may decrease MBOAT7 expression independent of these polymorphisms. We hypoth...
Autores principales: | Sharpe, Martin C., Pyles, Kelly D., Hallcox, Taylor, Kamm, Dakota R., Piechowski, Michaela, Fisk, Bryan, Albert, Carolyn J., Carpenter, Danielle H., Ulmasov, Barbara, Ford, David A., Neuschwander-Tetri, Brent A., McCommis, Kyle S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249591/ https://www.ncbi.nlm.nih.gov/pubmed/37293574 http://dx.doi.org/10.1016/j.gastha.2023.02.004 |
Ejemplares similares
-
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
por: Mukherjee, Sandip, et al.
Publicado: (2021) -
The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020) -
Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
por: Yuan, Liyun, et al.
Publicado: (2021) -
An Inhibitor of Arginine‐Glycine‐Aspartate‐Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis
por: Ulmasov, Barbara, et al.
Publicado: (2018) -
Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
por: Kamm, Dakota R., et al.
Publicado: (2021)